Skip to main content
Terug
Watch Compare

CV Sciences, Inc.

Datakwaliteit: 100%
CVSI
OTC Manufacturing Chemicals
€ 0,04
▲ € 0,01 (33,33%)
Marktkapitalisatie: 5,80 M
Prijs
€ 0,03
Marktkapitalisatie
5,80 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -8,93% annually over 5 years
Negative free cash flow of -516.000,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,27%
Capital efficient — spends only 0,79% of revenue on capex

Groei

Revenue Growth (5Y)
-8,93%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-12,20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-57,33%
Onder sectorgemiddelde (-54,47%)
ROIC-16,67%
Net Margin-6,95%
Op. Margin-3,41%

Veiligheid

Debt / Equity
0,83
Boven sectorgemiddelde (0,30)
Current Ratio1,06
Interest Coverage-0,91

Waardering

PE (TTM)
-6,06
Onder sectorgemiddelde (-1,49)
P/B Ratio3,77
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -6,1 -1,5
P/B 3,8 1,6
ROE % -57,3 -54,5
Net Margin % -7,0 -41,5
Rev Growth 5Y % -8,9 1,8
D/E 0,8 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q32022 N/A -€ 0,01 —
Q22022 -€ 0,03 -€ 0,02 +33,3%
Q12022 -€ 0,03 -€ 0,03 0,0%
Q42021 -€ 0,02 -€ 0,02 0,0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -12,20% Revenue Growth (3Y) -7,18%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -8,93% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 13,79 M Net Income (TTM) -958.000,0
ROE -57,33% ROA -12,82%
Gross Margin 48,97% Operating Margin -3,41%
Net Margin -6,95% Free Cash Flow (TTM) -516.000,0
ROIC -16,67% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,83 Current Ratio 1,06
Interest Coverage -0,91 Asset Turnover 1,85
Working Capital 311.000 Tangible Book Value 447.000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6,06 Forward P/E N/A
P/B Ratio 3,77 P/S Ratio 0,42
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8,89%
Market Cap 5,80 M Enterprise Value 7,08 M
Per Share
EPS (Diluted TTM) -0,01 Revenue / Share 0,07
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,79% FCF Conversion 53,86%
SBC-Adj. FCF -977.000 Growth Momentum -3,27

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 13,79 M 15,71 M 16,00 M 16,21 M 20,05 M
Net Income -958.000,0 -2,39 M 3,10 M -8,21 M -15,55 M
EPS (Diluted) -0,01 -0,01 0,02 -0,07 -0,14
Gross Profit 6,75 M 7,17 M 7,09 M 5,55 M 8,62 M
Operating Income -470.000,0 -2,19 M 3,36 M -6,85 M -18,45 M
EBITDA — — — — —
R&D Expenses 122.000,0 118.000,0 151.000,0 307.000,0 1,19 M
SG&A Expenses 7,62 M 9,24 M 9,75 M — 25,88 M
D&A 192.000,0 334.000,0 235.000,0 992.000,0 1,15 M
Interest Expense 517.000,0 — 600.000,0 600.000,0 -140.000,0
Income Tax 9.000,0 -8.000,0 -6.000,0 -47.000,0 -87.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6,96 M 7,93 M 9,20 M 12,74 M 18,07 M
Total Liabilities 5,49 M 6,13 M 6,30 M 13,51 M 14,52 M
Shareholders' Equity 1,47 M 1,80 M 2,90 M -777.000,0 3,54 M
Total Debt 1,65 M — — — 0,0
Cash & Equivalents — — — 611.000,0 1,38 M
Current Assets 5,13 M 6,24 M 7,94 M 11,13 M 14,19 M
Current Liabilities 5,00 M 6,11 M 6,12 M 13,31 M 14,46 M